Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Muir

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Nature Clinical Practice. Gastroenterology & Hepatology|December 6, 2005
HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?Andrew J Muir
Topics in Antiviral Medicine|November 15, 2014
Cirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C careAndrew J Muir
Journal of Clinical Gastroenterology|March 2, 2002
A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infectionAndrew J Muir, Dawn Provenzale
Current HIV/AIDS Reports|January 15, 2020
Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide EliminationSelin Ocal, Andrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2015
Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?Andrew J Muir, Susanna Naggie
Clinics in Liver Disease|December 14, 2006
Treatment of hepatitis C in special populationsMeera Ramamurthy, Andrew J Muir
Clinical Liver Disease|May 13, 2020
A Big Step Forward in Hepatitis C ScreeningNikhil Kapila, Andrew J Muir
Annual Review of Medicine|October 1, 2016
Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet NeedsSusanna Naggie, Andrew J Muir
Clinical Liver Disease|May 2, 2019
Integrating daclatasvir into hepatitis c therapyOmobonike Oloruntoba, Andrew J Muir
Current Hepatology Reports|June 7, 2017
Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-acting AntiviralsYuval A Patel, Andrew J Muir
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Nature Clinical Practice. Gastroenterology & Hepatology|December 6, 2005
HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?Andrew J Muir
Topics in Antiviral Medicine|November 15, 2014
Cirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C careAndrew J Muir
Journal of Clinical Gastroenterology|March 2, 2002
A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infectionAndrew J Muir, Dawn Provenzale
Current HIV/AIDS Reports|January 15, 2020
Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide EliminationSelin Ocal, Andrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2015
Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?Andrew J Muir, Susanna Naggie
Clinics in Liver Disease|December 14, 2006
Treatment of hepatitis C in special populationsMeera Ramamurthy, Andrew J Muir
Clinical Liver Disease|May 13, 2020
A Big Step Forward in Hepatitis C ScreeningNikhil Kapila, Andrew J Muir
Annual Review of Medicine|October 1, 2016
Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet NeedsSusanna Naggie, Andrew J Muir
Clinical Liver Disease|May 2, 2019
Integrating daclatasvir into hepatitis c therapyOmobonike Oloruntoba, Andrew J Muir
Current Hepatology Reports|June 7, 2017
Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-acting AntiviralsYuval A Patel, Andrew J Muir
Pageof 19